“Boehringer has had a successful year as one of the leading research investors in the industry. Our impressive pipeline is coming together nicely, with many contributions from clinical trial sites in Australia and New Zealand," said Dirk Otto, the general manager of Boehringer Ingelheim Australia and New Zealand. …
'We celebrate our 60th anniversary in Australia, I am extremely optimistic about the next 60'
April 17, 2024 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The industry is probably right to resist, it just needs to prepare for the response
December 16, 2025 - - Latest News -
Cynata completes patient enrolment in Phase 2 trial for aGvHD therapy
December 15, 2025 - - Australian Biotech -
Prescient secures European approval to launch PTX-100 trial for rare lymphoma
December 15, 2025 - - Australian Biotech -
Orthocell lodges European and UK regulatory application for Remplir
December 15, 2025 - - Australian Biotech -
Neuren wins second FDA approval for trofinetide with launch of formulation
December 15, 2025 - - Australian Biotech -
Dimerix completes adult recruitment in Phase 3 trial for FSGS treatment DMX-200
December 15, 2025 - - Australian Biotech -
Radiopharm Theranostics reports high success rate in Phase 2b imaging trial
December 15, 2025 - - Australian Biotech